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In the gastrointestinal tract, interstitial cells of Cajal (ICCs) act as pacemaker cells to generate slow wave activity. Interstitial cells
that resemble ICCs in the gastrointestinal tract have been identiﬁed by their morphological characteristics in the bladder. KIT is
used as an identiﬁcation marker of ICCs. ICCs in the bladder may be involved in signal transmission between smooth muscle
bundles, from eﬀerent nerves to smooth muscles, and from the urothelium to aﬀerent nerves. Recent research has suggested that
not only the disturbance of spontaneous contractility caused by altered detrusor ICC signal transduction between nerves and
smooth muscle cells but also the disturbance of signal transduction between urothelial cells and sensory nerves via suburothelial
ICC may induce overactive bladder (OAB). Recent reports have suggested that KIT is not only a detection marker of these cells,
but also may play a crucial role in the control of bladder function. Research into the eﬀect of a c-kit receptor inhibitor, imatinib
mesylate, on bladder function implies that KIT-positive ICCs may be therapeutic target cells to reduce bladder overactivity and
that the blockage of c-kit receptor may oﬀer a new therapeutic strategy for OAB treatment, although further study will be needed.
1.Introduction
Overactive bladder (OAB) syndrome is characterized by
urinary frequency and urgency with or without urge incon-
tinence, and is often accompanied by nocturia. In the USA
population, 16.5% (16% of men and 16.9% of women) over
18 years of age had symptoms consistent with OAB [1]. The
prevalence of this condition increases with age, and OAB
signiﬁcantly impacts health-related quality of life [1–3].
Urgency is the core symptom of the OAB symptom com-
plex, but the underlying mechanisms are not fully under-
stood [4]. OAB symptoms were traditionally considered to
result from overactivity of the bladder detrusor muscle.
Drake et al. showed model of peripheral autonomous mod-
ules and a myovesical plexus in normal and OAB function,
and detrusor overactivity (DO) results from exaggerated
symptomatic expression of peripheral autonomous activity,
resulting from a shift in the balance of excitation and inhi-
bition in smooth muscle modules [5]. On the other hand,
there is increasing evidence showing that the urothelium
has specialized sensory and signaling properties, and may
mediate urgency [6, 7]. In addition, the role of interstitial
cells in mediating urgency and the pathophysiology of OAB
has recently attracted considerable attention.
In the gastrointestinal tract, interstitial cells of Cajal
(ICC) act as primary pacemaker cells which inject depolar-
izing currents into neighboring smooth muscles to initiate
spontaneous slow waves and corresponding phasic contrac-
tions [8], and play a fundamental role in the transmission
o fs i g n a l sf r o me n t e r i cn e u r o n st os m o o t hm u s c l ec e l l s[ 9].
ICCs express the proto-oncogene c-kit, and signaling via the
receptor kinase gene product, KIT [10] ,w h i c hi su s e da sa n
identiﬁcation marker of ICCs. In the urinary tract, including
the renal pelvis, ureter, bladder, and urethra, KIT-positive
ICCs, which are referred to as interstitial cells (IC), ICC-
like cells, or myoﬁbroblasts [11], have also been identiﬁed
by their morphological characteristics [5, 12, 13], but show
variability among tissues, which may account for individual
characteristics of the organs [13].
Many groups have attempted to elucidate their physio-
logicalfeaturesinthebladder,buthaveshownthatICCinthe
bladder does not necessarily have the typical physiological2 Advances in Urology
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Figure 1: Distribution and morphology of Kit-positive suburothelial and detrusor ICCs and interaction with urothelium, nerves, and
smooth muscle.
function of ICC in the gastrointestinal tract [11]. Identifying
the functions of ICCs may be a shortcut to clarify the
pathophysiology of OAB and DO. Thus, in this review, we
summarize the distribution and function of KIT-positive
ICC in the bladder as well as the association between KIT-
possitive ICCs and OAB, and discuss the possible therapeutic
target of KIT-positive ICC for OAB in the future.
2. Distribution and Morphology of
KIT-PositiveICC
ICC has immunoreactivity for vimentin, connexin-43, and
cGMP [14–16]. In addition, vanilloid, purinergic, and mus-
carinic receptors were expressed on suburothelial ICCs [17–
19]. On the other hand, KIT, which is expressed by ICC
but not smooth muscle or ﬁbroblasts [9, 10], is a well-
established detection marker of ICC; however, deﬁnitive evi-
dence remains lacking whether KIT was expressed in other
structures in the bladder. Some researchers demonstrated
that the presence of ICC in the urinary bladder has been
demonstrated using antibodies to KIT (also known as c-
kit) in rodents and humans. ICCs in the bladder are located
throughout the bladder wall [20] and can be divided into at
least two subpopulations by their morphology and orienta-
tion,thatis,ICCsindetrusorsmoothmusclelayers(detrusor
ICCs) and ICCs in the suburothelial layers (suburothelial
ICCs) [15, 20, 21]. These ICCs are closely associated with
detrusor smooth muscles and make structural interactions
with cholinergic nerves in each region [15, 20–22].
In the detrusor smooth muscle layer, ICCs are preferen-
tially located along the boundary of smooth muscle bundles
and are also distributed between muscle bundles. They run
in parallel with the smooth muscle bundles and are closely
associatedwithintramuralnerves[20].Thesemorphological
ﬁndings suggest that ICCs in the bladder may act as pace-
makers like those in the gastrointestinal tract as well as
playing an important role in cell-to-cell communication to
integrate signals in the bladder wall, although the hypothesis
of the role of ICCs in the urinary bladder as pacemaker cells
has remained controversial.
Suburothelial ICCs, which are also referred to as myoﬁ-
broblasts, have a spindle- and stellate-shaped morphology
with several branches emanating from a central soma [11,
20–23]. They are extensively linked by gap junctions to form
a functional syncytium [15]. In addition, double-labeling
with KIT and a nerve detection marker, PGP9.5, demon-
strated that ICCs are in close apposition to one another and
nerves, and form a interconnected cellular network [14],
supposedly involved in signaling pathways of the bladder,
and may play a role in moderating the sensory process, lead-
ing to the initiation of the micturition reﬂex [15]( Figure 1).
ICCs in the bladder were also distinguishable from other
cells by their unique ultrastructural features. There are
several reports of ultrastructural characterization of ICC
observedbytransmissionelectronmicroscopy[6,14,23,24].
A fundamental feature of ICCs is spindle- or stellate-shaped
cells with pale eosinophilic cytoplasm and an elongated
electron-dense nucleus (Figure 2). A critical element in the
ultrastructure of these cells is the ﬁbronexus, a cell-to-matrix
junction, consisting of myoﬁlament and ﬁbronectin ﬁlament
systems converging on a discrete cell-surface plaque [24].
Rasmussen et al. reported detailed information of the ultra-
structure of detrusor ICCs, and revealed two diﬀerent types
of ICC in the human detrusor smooth muscle layer: a CD34-
positive, CD-117-negative cell with a slender cytoplasmic
process and myoid features, and a ﬁbroblast-like cell. They
concluded that detrusor ICCs may be analogous to ICC in
the gastrointestinal tract. Wiseman et al. reported the char-
acteristics of suburothelial ICCs [16], showing a layer of
cells with the cytological characteristics of both ﬁbroblasts
and smooth muscle cells, and that ICCs included bundles
of ﬁne cytoplasmic ﬁlaments, dense bodies, linear arrays of
subsurface vacuoles, and the presence of an interrupted basal
lamina. These cells had close contact with unmyelinated
axonal varicosities containing a mixture of clear and largeAdvances in Urology 3
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Figure 2: Electron micrographs of ICC-LC in the guinea-pig bladder. ICC-LCs made close contact with nerves and each other. Arrow: ICC,
arrowhead: nerves, ×4,000.
dense-cored vesicles, or clear vesicles alone. Johnston et al.
havealsoshowntheultrastructuralproﬁleofICCs,including
an absent thick ﬁlament, dense bodies or dense bands typical
of smooth muscle cells, and mitochondria, ribosomes, ves-
icles,Golgi,andawell-developednondilated rER[23].These
morphologicalstudiesprovideabasisforfuturemorphologi-
calandphysiologicalinvestigationsofICCsunderconditions
of impaired bladder function.
3. Function of Kit-Positive ICC
ICCs in the gastrointestinal tract are known to be the origin
ofpacemakersignalsthatunderlietheirspontaneousactivity,
andtheyhaveamajorroleinthetransmissionofsignalsfrom
entericneuronstosmoothmusclecells[25,26].Similarly,the
bladder develops phasic or autonomous activity consisting
of rhythmical transient contractions during the ﬁlling phase
[27,28];however,singlemyocytescangenerateactionpoten-
tials, but not spontaneously [27]. Hashitani et al. reported
that spontaneous action potentials and associated calcium
waves occur almost simultaneously along the boundary of
bladder smooth muscle bundles and then propagate to the
otherboundary,probablythroughgapjunctions[29].Recent
evidence suggests that ICCs in the bladder may also play
a role in determining the pattern of spontaneous activity,
although their precise role is less well established in the
urinary tract than in the gastrointestinal tract [30–32].
Therefore, one of the main focuses of some researchers is to
identify the role of ICCs as either pacemaker cells to drive the
smooth muscle wall or as intermediaries in neuromuscular
transmission in the bladder.
WhetherICCscanactaspacemakercellsremainscontro-
versial.Asdescribedabove,inthedetrusormusclelayer,ICCs
are found preferentially at the boundary of muscle bundles
from where spontaneous Ca2+ transients originate, suggest-
ing that they may be crucial in generating spontaneous
excitation [21]. On the other hand, Hashitani et al. reported
that spontaneous Ca2+ transients recorded from ICCs in fact
occurred independently of those of smooth muscles even
when synchronous Ca2+ waves swept across muscle bundles
[33]. ICCs may be more important in mediating the propa-
gation of action potentials along the bundles than in actually
generating them [27, 29]. The ﬁnding in the human bladder
that c-kit labeling showed signiﬁcantly more ICCs in human
OAB detrusor than in normal specimens [34]m a ys u p p o r t
this suggestion, since in these tissues the contractions appear
better coordinated across the strips [20]; therefore, they may
not be electrical pacemaker cells.
Recently, it has been suggested that ICCs may func-
tion as sensing network receiving/sending signals from/to
the urothelium, modulating aﬀerent bladder innervations,
and/or activating a spinal or intramural reﬂex arc [35]. Sui
et al. demonstrated that suburothelial ICCs respond to ex-
ogenous agents implicated in modulating bladder sensory
responses; responses augmented by physical intercellular
contact [36]. Not only detrusor ICCs but also suburothelial
ICCs show spontaneous electrical and Ca2+ signaling [22,
23, 33, 37, 38]. They also respond to exogenous application
of neurotransmitters such as adenosine triphosphate (ATP)
and acetylcholine (Ach), and express purinergic (P2Y6),
cholinergic (M3) receptors, and prostaglandin receptor types
1a n d2( E P 1a n dE P 2 )[ 18, 19, 23, 39]. These ﬁndings
suggest that ICCs act in the sensory processes of the bladder
by responding to ATP, Ach, and prostaglandin, and might
play an important functional role in the control of bladder
function. In addition, other transmitters, such as connexin-
43 (gap junctions, e.g., intercellular communication) and
cGMP (responds to nitric oxide; NO) expressed by ICCs, are
probably very important for normal and pathologic (OAB)
physiology [15, 29].
AlthoughKITisusedasanidentiﬁcationmarkerofICCs,
recent reports have suggested that KIT is not only a detection
marker of these cells, but also may play a crucial role in
the control of bladder function [34, 40]. Several reports4 Advances in Urology
have evaluated the role of KIT using KIT mutant mice and
rats [41–43]. McCloskey et al. have recently reported the
physiological function of ICC-like cells in the bladder using
heterozygous KIT mutant mice (W/Wv), which have a point
mutation at amino acid 660 in c-kit that causes a reduction
but not abolition of tyrosine kinase activity. These mice
had KIT- and vimentin-immunopositive ICC, and there are
similarities in the electrical and contractile properties of
W/Wv and wildtype detrusors [44]. On the other hand,
homozygous KIT mutant WsRC Ws/Ws rats, which have a
12-basedeletioninthetyrosinekinasedomainofc-kitcDNA
rats [41], have impaired pacemaker activity in the ileum
and colon, which induced movement disturbance [42, 43].
We investigated morphological and physiological ﬁndings in
the bladder of KIT mutant rats in order to clarify whether
disturbance of the KIT pathways aﬀects bladder activity [45].
EachparameterofcystometryinKITmutantratswassimilar
to that of wildtype rats under normal conditions. Interest-
ingly, however, the reduction in intercontraction intervals in
KIT mutant rats with chemical cystitis was smaller than in
wildtype rats, suggesting reduced noxious bladder sensations
in KIT mutant rats. These results indicate that KIT plays
an important role in bladder function, especially under
pathological conditions, and certain voiding disturbances
may be associated with impaired KIT signaling in ICCs.
Stem cell factor (SCF), a natural ligand for KIT, is asso-
ciated with various biologic phases, such as hematopoiesis,
reproduction, regeneration, and cell proliferation [46]; how-
ever, the distribution and role of SCF in the urinary bladder
remains unknown, although the role of c-kit in the urinary
bladder has been gradually clariﬁed. Our preliminary data
suggest that SCF produced in the urothelium of the urinary
bladder may act as a possible mediator by binding to c-kit
[47]. The SCF/c-kit pathway leads to the activation of
multiple pathways,including phosphatidyl-inositol-3 kinase,
phospholipase C-gamma, Src kinase, Janus kinase/signal
transducers, and activators of transcription and mitogen-
activated protein kinase pathways [48]. Recognition of the
biological properties and elucidation of the mechanism of
the SCF/c-kit pathway in the bladder may provide more
insight into the physiology of the bladder.
4.KIT-PositiveICCandPathophysiology
of OAB and DO
Human gastrointestinal motility disorders, such as gas-
troparesis, chronic idiopathic intestinal pseudoobstruction,
achalasia, and chronic constipation, have been associated
with loss of ICC in dysfunctional regions of the gastroin-
testinal tract [49]. Although little is known about the role of
ICCs in the bladder, the present knowledge suggests that the
functions of ICCs may be region-speciﬁc, particularly under
pathological conditions [50]. There have been reports of the
correlation between ICCs in the bladder and OAB or DO.
Biers et al. demonstrated that c-kit-positive ICCs are more
numerous in human OAB detrusor than normal detrusor
[34], suggesting that detrusor ICC is associated with the
pathophysiology of OAB. Under OAB conditions, increased
electricalcouplingbetweensmoothmusclecellsmayaccount
for enhanced excitability of detrusor smooth muscles [51].
Thus, spontaneous excitation resulting from spontaneous
action potentials [52] may spread for a longer distance and
cause synchronous contractions of multiple muscle bundles
to elevate intravesical pressure [13]. Indeed, micromotions
of the bladder wall, which may be attributed to spontaneous
contractions of a unit of muscle bundles, have been reported
to be enhanced in a rat model of bladder overactivity [53].
Although the urinary bladder urothelium has classically
been thought of as a passive barrier, recent studies have
demonstrated that the urothelium is involved in sensory
mechanisms and releases several bioactive mediators, such
as ATP, nitric oxide, and acetylcholine. Although a neuro-
genic basis has been considered for the changes in both
eﬀerent and aﬀerent autonomic nerves, the role of increased
signal transmission from the urothelium to aﬀerent nerves
via suburothelial ICCs during the micturition reﬂex has
attracted particular considerable attention [54]. Therefore,
several researchers have focused on the correlation between
suburothelial ICCs and the pathophysiology of OAB and
DO, because they may play an important role in signal
transmission and be responsible for bladder control. We
investigated the distribution of ICCs in guinea-pigs with
partial bladder outlet obstruction (PBOO), which showed
bladder overactivity in cystometry [55]. The population
of KIT or vimentin immunoreactive ICCs was increased
in subserosal layers and their distribution was altered in
the suburothelial layer in PBOO bladders, suggesting that
the altered distribution of ICCs may contribute to the
pathophysiology of bladder overactivity. Therefore, not only
the disturbance of spontaneous contractility caused by
altered ICC signal transduction between nerves and smooth
muscle cells in the detrusor smooth muscle layer but also the
disturbance of signal transduction between urothelial cells
and sensory nerves via suburothelial ICC may induce OAB
and DO. In addition, ultrastructural features of ICC changed
in the PBOO model. This may produce abnormal signal
transduction between ICC and the nerves or smooth muscle
cells [55], suggesting that quantitative or qualitative changes
in ICCs may account for the pathologically increased signal
transmission between either homogenous or heterogeneous
populations of cells in the bladder wall; however, since the
pathophysiology of human OAB is not necessarily consistent
with pBOO-induced detrusor overactivity, further study
using human OAB specimens will be needed.
5.KIT-PositiveICCasaTherapeuticTargetfor
OAB in the Future
Normal physiological contraction of the urinary bladder is
predominantly mediated by muscarinic receptors, primarily
the M3 subtype, with the M2 subtype playing a secondary
backup role. On the other hand, bladder relaxation seems to
be mediated by β-adrenoceptors, in most species involving a
strong β3 component; therefore, interference with the signal
transduction of these receptors may be a viable approach
to develop drugs for the treatment of OAB [56]. It isAdvances in Urology 5
well established that antimuscarinic drugs are eﬀective in
reducing symptoms and improving the quality of life of
patients with OAB. Currently, antimuscarinic drugs are the
ﬁrstchoiceinthepharmacologicaltreatmentofOAB.Besides
their status as the current standard of care, compliance and
persistence are often aﬀected by adverse eﬀects. Although
selective β3-adrenoceptor agonists are potentially useful
agents for treating OAB, other options of medical treatment
for OAB will be needed.
Imatinib mesylate (Glivec) is a selective inhibitor of
c-kit receptor tyrosine kinase and the oncogene Bcr-Abl,
and has Food and Drug Administration approval for the
treatment of chronic myeloid leukemia and gastrointestinal
stromal tumor. Several researchers have demonstrated that
inhibition of c-kit reduced bladder activity via c-kit receptor
on bladder ICCs [15, 34, 35, 40, 57]. We examined the eﬀects
of imatinib mesylate on spontaneous excitation and ion
channel activity in detrusor smooth muscles of the guinea-
pig bladder using intracellular microelectrodes, isometric
muscle tension recordings and patch clamp techniques [57].
Imatinib mesylate (10 microM) converted action potential
bursts into continuous ﬁring without aﬀecting their shape
but at 50 microM abolished spontaneous action potentials
in single smooth muscle cells. It had little eﬀect on inward
and outward currents at <10μM, but inhibited them at
>50μM. We also investigated the eﬀects of imatinib mesylate
on intravesical pressure of isolated guinea-pig bladders
using whole organ bath techniques, and demonstrated that
imatinib mesylate reduced the amplitude of spontaneous
pressure rises in the whole bladder in a dose-dependent
manner [40]. The results suggest that ICC-like cells may be
responsible for generating bursts of action potentials and
contractions in detrusor smooth muscle. Biers et al. demon-
strated that imatinib mesylate inhibited evoked smooth
muscle contraction and spontaneous activity in human OAB
d e t r u s o r ,w i t hl e s se ﬀect on normal human tissue [34]. They
also demonstrated that imatinib mesylate improved bladder
capacity, compliance, voided volume, urinary frequency and
reduced contraction thresholds and spontaneous activity
duringguineapigcystometry[34].Vahabietal.haverecently
reported that imatinib mesylate decreased the amplitude and
frequency of carbacol-induced phasic contractions in both
normal and diabetic tissues in a dose-dependent manner
[35]. These reports showed that imatinib mesylate inhibited
spontaneous contraction and, as a result, probably reduced
OAB symptoms. On the other hand, as described above,
bladder suburothelial ICCs may modulate both sensory
responses from the bladder wall and spontaneous activity.
Sui et al. showed that several responses that inﬂuenced
bladder activity either directly or through activation of the
sensorymechanismweresigniﬁcantlyaugmentedbyphysical
connections between adjacent cells, and such augmentation
was abolished by imatinib mesylate [36]. They also found
that imatinib mesylate reduced spontaneous contractile
activity in the isolated bladder. Although more data about
the potential of ICC as target cells will be needed before the
clinical implications of these ﬁndings are elucidated, KIT-
positive ICCs may be one of the therapeutic target cells to
reduce bladder overactivity and blocking c-kit receptor may
oﬀer a new therapeutic strategy for OAB treatment in the
future.
6. Conclusions
The current limitations of improving OAB therapies arise
from our lack of knowledge regarding the primary patho-
physiologyofthisdisease.Clarifying theroleofICCfunction
in the bladder may lead to greater understanding of the
mechanisms of OAB, and provide a novel therapeutic target.
KIT-positive ICCs may be involved in signal transmission,
between smooth muscle bundles, from eﬀerent nerves to
smooth muscles and from urothelium to aﬀerent nerves,
and thus could be a crucial target for the pharmacological
treatment of OAB and DO in the future; however, since the
role of KIT in the urinary bladder is still not fully clariﬁed,
f u r t h e ri n v e s t i g a t i o na n dm o r ee v i d e n c ew i l lb en e e d e d .
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